The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-chloro-N-[5-(cyclopentylmethylsulfanyl)-1,3,4-thiadiazol-2-yl]-1,3-benzodioxole-5-carboxamide ID: ALA5289614
Max Phase: Preclinical
Molecular Formula: C16H16ClN3O3S2
Molecular Weight: 397.91
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1nnc(SCC2CCCC2)s1)c1cc2c(cc1Cl)OCO2
Standard InChI: InChI=1S/C16H16ClN3O3S2/c17-11-6-13-12(22-8-23-13)5-10(11)14(21)18-15-19-20-16(25-15)24-7-9-3-1-2-4-9/h5-6,9H,1-4,7-8H2,(H,18,19,21)
Standard InChI Key: XALPDHZZQDDISW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
-2.1099 0.1096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3131 -0.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7297 0.4795 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0995 -0.9006 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3027 -1.1141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2805 -0.5307 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.0257 -0.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8963 -1.7173 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0768 -1.8414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7401 -0.5098 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.4546 -0.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1689 -0.5098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1688 0.3149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9726 0.5650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4433 -0.0881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9516 -0.7555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6934 -0.4735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4875 -0.2598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7010 0.5370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1218 1.1185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3243 0.9097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4799 -1.2702 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-4.4433 0.9252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.3161 1.7163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5008 1.8414 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 1 0
6 5 1 0
6 7 1 0
7 8 2 0
9 8 1 0
5 9 2 0
7 10 1 0
10 11 1 0
11 12 1 0
13 12 1 0
13 14 1 0
14 15 1 0
16 15 1 0
12 16 1 0
17 1 2 0
18 17 1 0
19 18 2 0
20 19 1 0
21 20 2 0
1 21 1 0
17 22 1 0
19 23 1 0
23 24 1 0
25 24 1 0
20 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.91Molecular Weight (Monoisotopic): 397.0322AlogP: 4.45#Rotatable Bonds: 5Polar Surface Area: 73.34Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.21CX Basic pKa: ┄CX LogP: 4.63CX LogD: 4.26Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.59Np Likeness Score: -1.92
References 1. Dodd CJ, Chronister KS, Rathnayake U, Parr LC, Li K, Chang S, Mi D, Days EL, Bauer JA, Cho HP, Boutaud O, Denton JS, Lindsley CW, Han C.. (2023) Synthesis and SAR of a novel Kir6.2/SUR1 channel opener scaffold identified by HTS., 87 [PMID:36966977 ] [10.1016/j.bmcl.2023.129256 ]